Heron Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of HRTX for the last quarter is 36.02 M USD, and it's 3.91% higher compared to the previous quarter. The net income of Q2 24 is -9.23 M USD.